While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious towards the current bull run since March and hedging or reducing many of their long positions. Some fund managers are betting on Dow hitting […] …read more […]
Both political parties now have reason to hold off on a new stimulus bill until 2021. …read more […]
VANCOUVER, British Columbia, Nov. 09, 2020 — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company revolutionizing the delivery of healthcare to patients, is excited to […]
Shares of “work-from-home” names including Peloton, Netflix and Roku, fell on Monday following efficacy news on the COVID-19 vaccine front. Yahoo Finance Editor-at-Large breaks down the price action of these stocks. …read more […]
Victoria Fernandez, Chief Market Strategist at Crossmark Global Investments, joins Yahoo Finance Live to discuss market moves following positive news of Pfizer and BioNTech’s COVID-19 vaccine, and her outlook on “work-from-home” names including Zoom Video and Peloton. …read more […]
McDonald’s enters the plant-based meat craze on its own. …read more […]
Apple announced that the tech giant will hold a special event on November 10. Yahoo Finance’s Dan Howley shares what he expects from Apple’s third fall 2020 event. …read more […]
We feel now is a pretty good time to analyse Neos Therapeutics, Inc.’s (NASDAQ:NEOS) business as it appears the… …read more […]
Stocks are soaring today on upbeat vaccine data from Pfizer. Citi Private Bank Chief Investment Officer David Bailin joins Yahoo Finance Live to discuss. …read more […]
Firm’s largest sales of the 3rd quarter …read more […]
Oxford Economics’ Chief U.S. Economist Gregory Daco joins Yahoo Finance Live to discuss what news of the Pfizer vaccine means for the U.S. economy, and the key indicators to watch under a Biden administration. …read more […]
(Bloomberg) — The Covid-19 vaccine being developed by Pfizer and BioNTech prevented more than 90% of infections in a study, the most encouraging scientific advance so far in the battle against the coronavirus. Novavax’s experimental vaccine received a fast-track designation from U.S. regulators.Meanwhile, the pandemic shows no signs of slowing, with worldwide infections surpassing 50 million. Cases in the U.S. topped 100,000 for a fourth day, bringing the nation’s total close to the 10 million mark. U.S. President-elect Joe Biden announced a new 13-member coronavirus task force, and New Jersey is preparing more restrictions.Germany has more severe Covid patients than …read more […]
Teladoc Health, Inc. (NYSE:TDOC) shareholders will have a reason to smile today, with the analysts making substantial… …read more […]
Yahoo Finance’s Brian Sozzi, Myles Udland, and Julie Hyman discuss the timeline for a COVID-19 vaccine. …read more […]
In this article we are going to estimate the intrinsic value of Lowe’s Companies, Inc. (NYSE:LOW) by estimating the… …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
